Probi Stock

Probi Equity

Delisted

The The Equity of Probi (PROB.ST) as of Jul 31, 2026 is 1.37 B SEK. In the previous year, The Equity was 1.41 B SEK — a change of -2.94% (lower).

Equity

1.37 BSEK

YoY

-2.94%

Last updated:

In 2026, Probi's equity was 1.37 B SEK, a -2.94% increase from the 1.41 B SEK equity in the previous year.

Access this data via the Eulerpool API

Probi Stock analysis

What does Probi do? Probi AB is a Swedish company that specializes in the development and production of probiotic products. Founded in 1991 as a spin-off from Lund Institute of Technology, Probi is now represented in Sweden, the USA, and India with approximately 200 employees. The business model of Probi is based on research and development of probiotic bacterial cultures, as well as marketing probiotic products developed in collaboration with customers and partners. The company's business divisions are divided into probiotic products and research and development. Probiotic products: Probi produces a wide range of probiotic products, including dietary supplements, functional foods, animal feed, and medical devices. These products contain live microorganisms intended to support gut health and strengthen the immune system. Probi works closely with customers and partners to develop tailored solutions. Research and development: An important part of Probi's business is the research and development of probiotic bacterial cultures. Research findings serve as the basis for new products and applications. Probi has its own research department equipped with state-of-the-art laboratory technologies. In addition, Probi collaborates closely with partners from the academic and industrial sectors to explore new technologies and applications. Probi's history originally began in the 1980s at Lund Institute of Technology in Sweden, where the foundation for the development of probiotics was laid. In 1991, Probi was established as a spin-off from the institute, initially focusing on research and development of probiotic bacterial cultures. Over the following years, the company expanded internationally and developed more and more products and applications. Today, Probi is a leading global provider of probiotic products and solutions. Probi's products include probiotic capsules and tablets, probiotic yogurts, beverages, and dietary supplements. These products are intended to stabilize gut flora and strengthen the immune system. Additionally, Probi offers animal feed with probiotic bacterial cultures to promote the health of livestock. An important aspect of Probi is its collaboration with partners and customers. Through these partnerships, innovative products and solutions are developed to meet the needs of customers. Probi works closely with the food industry, healthcare sector, and animal feed industry. The future of Probi looks promising. The company aims to continue developing innovative products and solutions to promote the health of humans and animals. A strong growth strategy will also be pursued to further expand international presence. Probi is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Probi's Equity

Probi's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Probi's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Probi's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Probi's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Probi’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Probi stock

The Equity of Probi is 1.37 B SEK in 2026.

Access this data via the Eulerpool API

Balance Sheet — Probi

All Key Metrics — Probi